On February 9, 2026, the European Food Safety Authority (EFSA) updated its safety statement regarding cannabidiol (CBD) as a novel food. The update establishes a provisional safe intake level for CBD with a defined scope of application, outlines data gaps in its safety research, and confirms that EFSA will continue to advance the risk assessment of CBD.

Based on publicly available information from the Open EFSA and regulations issued by the European Commission, CIRS conducted a statistical analysis of the EU Novel Food (NF) approval status in 2025 for enterprise reference.

Based on publicly available information from the Open EFSA and regulations issued by the European Commission, CIRS conducted a statistical analysis of the 2025 EU food additive submissions for corporate reference.

As of December 31, 2025, according to the public information of the EU information retrieval platform Open EFSA, CIRS has conducted statistical analysis on the approval trends of Novel Food (hereinafter referred to as NF) in the EU in the fourth quarter of 2025.

On 3 November 2025, EFSA released its safety evaluation report on synthetic cannabidiol (CBD) as a novel food. According to the assessment conducted by EFSA’s expert panel, the safety of the NF synthetic CBD cannot be established.

As of September 30, 2025, according to the public information of the EU information retrieval platform Open EFSA, CIRS has conducted statistical analysis on the approval trends of Novel Food (hereinafter referred to as NF) in the EU in the third quarter of 2025.